Skip to main content
SpringerLink
Log in

Long-term outcome of peritoneal dialysis and hemodialysis in pediatric patients

  • Chapter
Book cover Pediatric Dialysis

Abstract

Pediatric patients have been taken onto dialysis treatment for the last 30 years and comprise approximately 2% of any national dialysis program1. Despite this, long-term outcome data for this special group are scarce, reflecting the relatively small numbers involved and the difficulties in tracking these patients beyond adolescence. Pediatric nephrologists are now starting dialysis treatment in infants and children with the expectation that a successful renal transplant is an achievable goal and will provide the best survival and quality of life for their patient. However some children will require long-term dialysis or may return intermittently to dialysis during the course of their end-stage renal failure (ESRF) management. This chapter reviews the available pediatric outcome data including some long-term observations from our unit and attempts to use the larger adult dialysis outcome experience to inform our pediatric practice. The multiple factors that may influence outcome for children on dialysis and in particular, those which can potentially be modified are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. US Renal Data System. Incidence and prevalence of ESRD. Am J Kidney Dis. 1998;32(Suppl 1):S38–49.

    Google Scholar 

  2. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–30.

    Article  PubMed  CAS  Google Scholar 

  3. Neu AM, Ho PL, McDonald RA, Warady BA. Chronic dialysis in children and adolescents. The 2001 NAPRTCS Annual Report. Pediatr Nephrol. 2002;17(8):656–63.

    Article  PubMed  Google Scholar 

  4. Wong CS, Hingorani S, Gillen DL, Sherrard DJ, Watkins SL, Brandt JR, Ball A, Stehman-Breen CO. Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int. 2002;61(2):630–7.

    Article  PubMed  Google Scholar 

  5. Wood EG, Hand M, Briscoe DM, Donaldson LA, Yiu V, Harley FL, Warady BA, Ellis EN. Risk factors for mortality in infants and young children on dialysis. Am J Kidney Dis. 2001;37(3):573–9.

    Article  PubMed  CAS  Google Scholar 

  6. Ellis EN, Pearson D, Champion B, Wood EG. Outcome of infants on chronic peritoneal dialysis. Adv Perit Dial. 1995;11:266–9.

    PubMed  CAS  Google Scholar 

  7. Ledermann SE, Scanes ME, Fernando ON, Duffy PG, Madden SJ, Trompeter RS. Long-term outcome of peritoneal dialysis in infants. J Pediatr. 2000;136(1):24–9.

    Article  PubMed  CAS  Google Scholar 

  8. Keane WF, Collins AJ. Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis. 1994;24(6):1010–18.

    PubMed  CAS  Google Scholar 

  9. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT. Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis. 2000;35(1):69–79.

    Article  PubMed  CAS  Google Scholar 

  10. Okechukwu CN, Lopes AA, Stack AG, Feng S, Wolfe RA, Port FK. Impact of years of dialysis therapy on mortality risk and the characteristics of longer term dialysis survivors. Am J Kidney Dis. 2002;39(3):533–8.

    Article  PubMed  Google Scholar 

  11. UK Renal Registry B, UK. UK Renal Registry Report. Third Annual Report; 2000.

    Google Scholar 

  12. Murphy SW, Foley RN, Barrett BJ, Kent GM, Morgan J, Barre P, Campbell P, Fine A, Goldstein MB, Handa SP, Jindal KK, Levin A, Mandin H, Muirhead N, Richardson RM, Parfrey PS. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int. 2000;57(4):1720–6.

    Article  PubMed  CAS  Google Scholar 

  13. Rabbat CG, Thorpe KE, Russell JD, Churchill DN. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol. 2000;11(5):917–22.

    PubMed  CAS  Google Scholar 

  14. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Clinical Practice Guidelines: Vascular access. Am J Kidney Dis. 1997;30(Suppl 3):S150–91.

    Google Scholar 

  15. The Renal Association. Treatment of Adults and Children with Renal Failure; Standards and Audit Measures, 3rd edn. Renal Association; 2002.

    Google Scholar 

  16. Jabs K, Warady BA. The impact of the Dialysis Outcomes Quality Initiative Guidelines on the care of the pediatric end-stage renal disease patient. Adv Ren Replace Ther. 1999;6(1):97–106.

    PubMed  CAS  Google Scholar 

  17. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62(2):620–6.

    Article  PubMed  Google Scholar 

  18. Andreoli SP, Leiser J, Warady BA, Schlichting L, Brewer ED, Watkins SL. Adverse effect of peritonitis on peritoneal membrane function in children on dialysis. Pediatr Nephrol. 1999;13(1):1–6.

    Article  PubMed  CAS  Google Scholar 

  19. Neiberger RE. Peritoneal membrane failure in children on peritoneal dialysis. Adv Perit Dial. 1995;11:277–80.

    PubMed  CAS  Google Scholar 

  20. Mallick NP, Hutchinson A, Patel M, Harty J. Factors influencing dialysis outcome: the dialysis dose in perspective. Nephrol Dial Transplant. 1998;13(Suppl 6):152–7.

    Article  PubMed  Google Scholar 

  21. Combe C, Chauveau P, Laville M, Fouque D, Azar R, Cano N, Canaud B, Roth H, Leverve X, Aparicio M. Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients. Am J Kidney Dis. 2001;37(lSuppl 2):S81–8.

    Article  PubMed  CAS  Google Scholar 

  22. Tom A, McCauley L, Bell L, Rodd C, Espinosa P, Yu G, Yu J, Girardin C, Sharma A. Growth during maintenance hemodialysis: impact of enhanced nutrition and clearance. J Pediatr. 1999;134(4):464–71.

    Article  PubMed  CAS  Google Scholar 

  23. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12(10):2158–62.

    PubMed  CAS  Google Scholar 

  24. Brem AS, Lambert C, Hill C, Kitsen J, Shemin DG. Clinical morbidity in pediatric dialysis patients: data from the Network 1 Clinical Indicators Project. Pediatr Nephrol. 2001;16(11):854–7.

    Article  PubMed  CAS  Google Scholar 

  25. Brem AS, Lambert C, Hill C, Kitsen J, Shemin DG. Outcome data on pediatric dialysis patients from the end-stage renal disease clinical indicators project. Am J Kidney Dis. 2000;36(2):310–17.

    Article  PubMed  CAS  Google Scholar 

  26. Holtta T, Ronnholm K, Jalanko H, Holmberg C. Clinical outcome of pediatric patients on peritoneal dialysis under adequacy control. Pediatr Nephrol. 2000;14(10-11):889–97.

    Article  PubMed  CAS  Google Scholar 

  27. Chadha V, Blowey DL, Warady BA. Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis? Perit Dial Int. 2001;21(Suppl 3):S179–84.

    PubMed  Google Scholar 

  28. Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR. Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol. 2002;17(6):450–5.

    Article  PubMed  Google Scholar 

  29. Foley RN, Parfrey PS, Harnett JD, Kent GM, O’Dea R, Murray DC, Barre PE. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol. 1998;9(2):267–76.

    PubMed  CAS  Google Scholar 

  30. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996;7(2):198–207.

    Google Scholar 

  31. Norman LJ, Coleman JE, Macdonald IA, Tomsett AM, Watson AR. Nutrition and growth in relation to severity of renal disease in children. Pediatr Nephrol. 2000;15(3-4):259–65.

    Article  PubMed  CAS  Google Scholar 

  32. Ledermann SE, Shaw V, Trompeter RS. Long-term enteral nutrition in infants and young children with chronic renal failure. Pediatr Nephrol. 1999;13(9):870–5.

    Article  PubMed  CAS  Google Scholar 

  33. Kari JA, Gonzalez C, Ledermann SE, Shaw V, Rees L. Outcome and growth of infants with severe chronic renal failure. Kidney Int. 2000;57(4):1681–7.

    Article  PubMed  CAS  Google Scholar 

  34. Wong CS, Gipson DS, Gillen DL, Emerson S, Koepsell T, Sherrard DJ, Watkins SL, Stehman-Breen C. Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis. 2000;36(4):811–19.

    Article  PubMed  CAS  Google Scholar 

  35. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112–19.

    Article  PubMed  CAS  Google Scholar 

  36. US Renal Data System. USRDS 2000 Annual Data Report. Bethesda; 2000.

    Google Scholar 

  37. Locatelli F, Marcelli D, Conte F, D’Amico M, Del Vecchio L, Limido A, Malberti F, Spotti D. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol. 2001;12(11):2411–17.

    PubMed  CAS  Google Scholar 

  38. Chavers BM, Li S, Collins AJ, Herzog CA. Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int. 2002;62(2):648–53.

    Article  PubMed  Google Scholar 

  39. Litwin M, Grenda R, Prokurat S, Abuauba M, Latoszynska J, Jobs K, Boguszewska-Baczkowska A, Wawer ZT. Patient survival and causes of death on hemodialysis and peritoneal dialysis-single-center study. Pediatr Nephrol. 2001;16(12):996–1001.

    Article  PubMed  CAS  Google Scholar 

  40. Kari JA, Donald AE, Vallance DT, Bruckdorfer KR, Leone A, Mullen MJ, Bunce T, Dorado B, Deanfield JE, Rees L. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 1997;52(2):468–72.

    Article  PubMed  CAS  Google Scholar 

  41. Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol. 2000;14(10-11):898–902.

    Article  PubMed  CAS  Google Scholar 

  42. Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, Powell HR. Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int. 1996;50(3):998–1006.

    Article  PubMed  CAS  Google Scholar 

  43. Owen WF, Madore F, Brenner BM. An observational study of cardiovascular characteristics of long-term end-stage renal disease survivors. Am J Kidney Dis. 1996;28(6):931–6.

    Article  PubMed  CAS  Google Scholar 

  44. Chavers B, Schnaper HW. Risk factors for cardiovascular disease in children on maintenance dialysis. Adv Ren Replace Ther. 2001;8(3):180–90.

    Article  PubMed  CAS  Google Scholar 

  45. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 1996;49(5):1379–85.

    Article  PubMed  CAS  Google Scholar 

  46. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999;34(1):125–34.

    Article  PubMed  CAS  Google Scholar 

  47. Lingens N, Soergel M, Loirat C, Busch C, Lemmer B, Scharer K. Ambulatory blood pressure monitoring in pediatric patients treated by regular haemodialysis and peritoneal dialysis. Pediatr Nephrol. 1995;9(2):167–72.

    Article  PubMed  CAS  Google Scholar 

  48. Sorof JM. Systolic hypertension in children: benign or beware? Pediatr Nephrol. 2001;16(6):517–25.

    Article  PubMed  CAS  Google Scholar 

  49. Ozkahya M, Ok E, Cirit M, Aydin S, Akcicek F, Basci A, Dorhout Mees EJ. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant. 1998;13(6):1489–93.

    Article  PubMed  CAS  Google Scholar 

  50. Sorof JM, Brewer ED, Portman RJ. Ambulatory blood pressure monitoring and interdialytic weight gain in children receiving chronic hemodialysis. Am J Kidney Dis. 1999;33(4):667–74.

    Article  PubMed  CAS  Google Scholar 

  51. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28(1):53–61.

    Article  PubMed  CAS  Google Scholar 

  52. Fink JC BS, Reddy M, Light PD. Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis. 2001;37(2):348–55.

    Article  PubMed  CAS  Google Scholar 

  53. Foley RN, Parfrey PS, Morgan J, Barre PE, Campbell P, Cartier P, Coyle D, Fine A, Handa P, Kingma I, Lau CY, Levin A, Mendelssohn D, Muirhead N, Murphy B, Plante RK, Posen G, Wells GA. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int. 2000;58(3):1325–35.

    Article  PubMed  CAS  Google Scholar 

  54. Gomez JM, Carrera F. What should the optimal target hemoglobin be? Kidney Int. 2002;61(Suppl 80):39–43.

    Article  Google Scholar 

  55. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis. 1997;30(4 Suppl 3):S192–240.

    Google Scholar 

  56. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337(4):230–6.

    Article  PubMed  CAS  Google Scholar 

  57. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274(19):1526–33.

    Article  PubMed  CAS  Google Scholar 

  58. Jungers P, Massy ZA, Khoa TN, Fumeron C, Labrunie M, Lacour B, Descamps-Latscha B, Man NK. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant. 1997;12(12):2597–602.

    Article  PubMed  CAS  Google Scholar 

  59. Moustapha A, Naso A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW, Robinson K, Dennis VW. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation. 1998;97(2):138–41.

    Article  PubMed  CAS  Google Scholar 

  60. Schroder CH, de Boer AW, Giesen AM, Monnens LA, Blom H. Treatment of hyperhomocysteinemia in children on dialysis by folic acid. Pediatr Nephrol. 1999;13(7):583–5.

    Article  PubMed  CAS  Google Scholar 

  61. Feinstein S, Sela BA, Drukker A, Becker-Cohen R, Raveh D, Gavendo S, Frishberg Y. Hyperhomocysteinemia in children on renal replacement therapy. Pediatr Nephrol. 2002;17(7):515–19.

    Article  PubMed  Google Scholar 

  62. Bellamy MF, McDowell IF, Ramsey MW, Brownlee M, Newcombe RG, Lewis MJ. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. Eur J Clin Invest. 1999;29(8):659–62.

    Article  PubMed  CAS  Google Scholar 

  63. Verhaar M, Wever R, Kastelein J et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial [see comments]. Circulation. 1999;100:335–8.

    Article  PubMed  CAS  Google Scholar 

  64. De Vriese AS, Verbeke F, Schrijvers BF, Lameire NH. Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure? Kidney Int. 2002;61(4):1199–209.

    Article  PubMed  Google Scholar 

  65. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest. 1996;98(1):5–7.

    Article  PubMed  CAS  Google Scholar 

  66. Bennett-Richards K, Kattenhorn M, Donald A, Oakley G, Varghese Z, Rees L, Deanfield JE. Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation. 2002;105(15):1810–15.

    Article  PubMed  CAS  Google Scholar 

  67. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478–83.

    Article  PubMed  CAS  Google Scholar 

  68. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106(1):100–5.

    Article  PubMed  Google Scholar 

  69. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38(4):938–42.

    Article  PubMed  CAS  Google Scholar 

  70. Amin N. The impact of improved phosphorus control: use of sevelamer hydrochloride in patients with chronic renal failure. Nephrol Dial Transplant. 2002;17(2):340–45.

    Article  PubMed  CAS  Google Scholar 

  71. Lowrie EG, Lew NL. Commonly measured laboratory variables in hemodialysis patients: relationships among them and to death risk. Semin Nephrol. 1992;12(3):276–83.

    PubMed  CAS  Google Scholar 

  72. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22.

    Article  Google Scholar 

  73. Kari JA, Shaw V, Vallance DT, Rees L. Effect of enteral feeding on lipid subfractions in children with chronic renal failure. Pediatr Nephrol. 1998;12(5):401–4.

    Article  PubMed  CAS  Google Scholar 

  74. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Corresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative Clinical Practice Guidelines for Chronic Kidney Disease in Children and adolescents: Evaluation, classification, and stratification. Pediatrics. 2003;111(6):1416–21.

    Article  PubMed  Google Scholar 

  75. Berard E, Crosnier H, Six-Beneton A, Chevallier T, Cochat P, Broyer M. Recombinant human growth hormone treatment of children on hemodialysis. French Society of Pediatric Nephrology. Pediatr Nephrol. 1998;12(4):304–10.

    Article  PubMed  CAS  Google Scholar 

  76. Morton MJ, Reynolds JM, Garralda ME, Postlethwaite RJ, Goh D. Psychiatric adjustment in end-stage renal disease: a follow up study of former pediatric patients. J Psychosom Res. 1994;38(4):293–303.

    Article  PubMed  CAS  Google Scholar 

  77. Groothoff JW, Grootenhuis M, Dommerholt A, Gruppen MP, Offringa M, Heymans HS. Impaired cognition and schooling in adults with end stage renal disease since childhood. Arch Dis Child. 2002;87(5):380–5.

    Article  PubMed  CAS  Google Scholar 

  78. Reynolds JM, Morton MJ, Garralda ME, Postlethwaite RJ, Goh D. Psychosocial adjustment of adult survivors of a pediatric dialysis and transplant programme. Arch Dis Child. 1993;68(1):104–10.

    Article  PubMed  CAS  Google Scholar 

  79. Gledhill J, Rangel L, Garralda E. Surviving chronic physical illness: psychosocial outcome in adult life. Arch Dis Child. 2000;83(2):104–10.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. Ledermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Rees
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Children’s Mercy Hospital, University of Missouri, Kansas City School of Medicine, Kansas City, MO, USA

    Bradley A. Warady

  2. University Children’s Hospital, Heidelberg, Germany

    Franz S. Schaefer

  3. Health Science Center, State University of New York at Stony Brook, Stony Brook, NY, USA

    Richard N. Fine

  4. Lucille Packard Children’s Hospital at Stanford, Stanford University, School of Medicine, Stanford, CA, USA

    Steven R. Alexander

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Ledermann, S., Rees, L. (2004). Long-term outcome of peritoneal dialysis and hemodialysis in pediatric patients. In: Warady, B.A., Schaefer, F.S., Fine, R.N., Alexander, S.R. (eds) Pediatric Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1031-3_29

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-1031-3_29

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-3770-9

  • Online ISBN: 978-94-007-1031-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation